EUVIMEDEUVIMED entdecken
Crossref

Chronic intermittent hypobaric hypoxia prevents pulmonary arterial hypertension through maintaining eNOS homeostasis

Hai-Shuang Li, Hui-Jie Liu, Yu Zhang, Jing Zhang, Han-Yu Yan, Wei-Cheng Yuan, Sen Wang, Shuo Yu, Sheng-Qiang Yang, Meng-Wei Sun, Can-Yang Qi, Sui-Bing Miao und 5 weitere

Archives of Biochemistry and Biophysics · 2025

DOI: 10.1016/j.abb.2025.110340 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2025. Verfasst von Hai-Shuang Li und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Hebei Medical University, Shijiazhuang, 050017, China. Hauptthemen laut MEDLINE: Hypoxia, Nitric Oxide Synthase Type III, Homeostasis, Pulmonary Arterial Hypertension. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Innovative Research Group Project of the National Natural Science Foundation of China, Hebei Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: Pulmonary arterial hypertension (PAH) is a pathological condition in which pulmonary artery pressure is elevated which causes patients to die of right heart failure. Chronic intermittent hypobaric hypoxia (CIHH) represents a novel method of intermittently exposing subjects to a simulated plateau hypobaric hypoxia environment. This study investigates the potential preventive and protective effects of CIHH on PAH. MAIN METHODS: Male Sprague-Dawley rats were randomly divided into four groups: control group (Con), chronic intermittent hypobaric hypoxia group (CIHH), pulmonary arterial hypertension group (PAH), chronic intermittent hypobaric hypoxia + pulmonary arterial hypertension group (CIHH + PAH). To evaluate the effects of CIHH on PAH, a range of techniques was employed, including pulmonary hemodynamics, vascular reactivity assay, Western blot, RNA sequencing, HE staining and co-immunoprecipitation. KEY FINDINGS: CIHH was demonstrated to reduce pulmonary artery constriction and enhance relaxation, reducing the mean pulmonary artery pressure in PAH rats. This is achieved through attenuating the CaM/eNOS (Calmodulin,CaM)protein interaction and increasing the CaV1/eNOS (Caveolin-1,CaV1) protein interaction, thereby preventing eNOS overactivation contribution to improving NO bioavailability in PAH rats. SIGNIFICANCE: CIHH prevents PAH by maintaining eNOS homeostasis in PAH rats.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypoxiaNitric Oxide Synthase Type IIIHomeostasisPulmonary Arterial HypertensionHypertension, PulmonaryAnimalsRats, Sprague-DawleyMaleRatsPulmonary ArteryCaveolin 1Calmodulin

Stichwörter der Autor:innen

CalmodulinCaveolin-1Chronic intermittent hypobaric hypoxiaNitric oxide synthase hyperactivationPulmonary artery hypertension

Substanzen

Nitric Oxide Synthase Type IIINos3 protein, ratCaveolin 1Calmodulin

Autor:innen und Institutionen

  • Department of Physiology, Hebei Medical University, Shijiazhuang, 050017, China.
  • Key Laboratory of Maternal and Fetal Medicine of Hebei Province, The Fourth Hospital of Shijiazhuang Affiliated to Hebei Medical University, Shijiazhuang, 050017, China.
  • Department of Gynaecology and Obstetrics, Fourth Hospital of Hebei Medical University, Shijiazhuang, 050017, China.
  • Department of Physiology, Hebei Medical University, Shijiazhuang, 050017, China; Hebei Key Laboratory of Neurophysiology, Shijiazhuang, 050017, China; The Key Laboratory of Neural and Vascular Biology, Ministry of Educa…
  • Department of Physiology, Hebei Medical University, Shijiazhuang, 050017, China; Hebei Key Laboratory of Neurophysiology, Shijiazhuang, 050017, China. Electronic address: guanyue@hebmu.edu.cn.

Förderung

  • Innovative Research Group Project of the National Natural Science Foundation of China
  • Hebei Provincial Natural Science Foundation

Zitieren

APA

Li, H. S., Liu, H. J., Zhang, Y., Zhang, J., Yan, H. Y., Yuan, W. C., Wang, S., Yu, S., Yang, S. Q., Sun, M. W., Qi, C. Y., Miao, S. B., Zhang, L. P., Guo, H., Zhang, Y., Ma, H. J., & Guan, Y. (2025). Chronic intermittent hypobaric hypoxia prevents pulmonary arterial hypertension through maintaining eNOS homeostasis. Archives of Biochemistry and Biophysics. https://doi.org/10.1016/j.abb.2025.110340

Vancouver

Li HS, Liu HJ, Zhang Y, Zhang J, Yan HY, Yuan WC, et al. Chronic intermittent hypobaric hypoxia prevents pulmonary arterial hypertension through maintaining eNOS homeostasis. Archives of Biochemistry and Biophysics. 2025. doi:10.1016/j.abb.2025.110340

BibTeX
@article{Li2025,
  author = {Li, Hai-Shuang and Liu, Hui-Jie and Zhang, Yu and Zhang, Jing and Yan, Han-Yu and Yuan, Wei-Cheng and Wang, Sen and Yu, Shuo and Yang, Sheng-Qiang and Sun, Meng-Wei and Qi, Can-Yang and Miao, Sui-Bing and Zhang, Li-Ping and Guo, Hui and Zhang, Yi and Ma, Hui-Jie and Guan, Yue},
  title = {Chronic intermittent hypobaric hypoxia prevents pulmonary arterial hypertension through maintaining eNOS homeostasis},
  journal = {Archives of Biochemistry and Biophysics},
  year = {2025},
  doi = {10.1016/j.abb.2025.110340}
}
Kostenlos starten →